McGinn OJ, Krishnan S, Bourquin J-P, Sapra P, Dempsey C, Saha V, Stern PL. Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia. Haematologica 2017; 102(6):1075-1084; https://doi.org/10.3324/haematol.2016.158485.